Edition:
United States

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.09USD
1:21pm EDT
Change (% chg)

$0.04 (+0.79%)
Prev Close
$5.05
Open
$5.05
Day's High
$5.10
Day's Low
$4.83
Volume
35,725
Avg. Vol
119,622
52-wk High
$9.69
52-wk Low
$4.44

Chart for

About

Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $272.88
Shares Outstanding(Mil.): 54.03
Dividend: --
Yield (%): --

Financials

  PIRS.OQ Industry Sector
P/E (TTM): -- 119.85 32.14
EPS (TTM): -0.17 -- --
ROI: -9.44 1.96 12.83
ROE: -26.25 1.12 14.95

BRIEF-Pieris Pharmaceuticals Reports Q1 Loss Per Share $0.17

* PIERIS PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

May 10 2018

Earnings vs. Estimates